VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

203

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

January 11, 2023

Study Completion Date

January 11, 2023

Conditions
Multiple Myeloma
Trial Locations (24)

Unknown

Soonchunhyang University Bucheon hospital, Bucheon-si

Inje university Haeundae Paik Hospital, Busan

Kosin University Gospel hospital, Busan

Pusan national University Hospital, Busan

Keimyung University Hospital(Dongsan Medical Center), Daegu

Yeungnam University Medical Center, Daegu

Chungnam National University Hospital, Daejeon

National Cancer Center, Goyang

Gyeongsang National University Changwon Hospital, Gyeongsang

Chonnam National University Hwasun Hospital, Hwasun

Gachon University Gil Medical Center, Incheon

Chungbuk national university Hospital, Jungbuk

Dankook University Hospital, Jungnam

Chung-Ang University Hospital, Seoul

Kangbuk Samsung Hospital, Seoul

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

Soonchunhyang University Hospital, Seoul

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul

Ajou University Medical Center, Suwon

Ulsan University hospital, Ulsan

Wonju Severance Christian Hospital, Wŏnju

All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY